News & Perspective

(CIDRAP News) – A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.

(CIDRAP News) – During the 2009 H1N1 pandemic, when colleges faced unique challenges, a group of large US universities found that preparedness paid off and that students were able to play a key role in response efforts, according to a new report.

(CIDRAP News) – The external committee tasked with reviewing the World Health Organization's (WHO's) response to the H1N1 pandemic wrapped up its third round of live meetings in Geneva today, hearing from an array of country and organization health representatives, as well as WHO Director-General Margaret Chan, who strongly defended the organization's response.

(CIDRAP News) – Two private risk-communication consultants who have done work for the World Health Organization (WHO) have published an analysis arguing that the agency's messaging missteps have lent undeserved credibility to accusations that it exaggerated the H1N1 pandemic threat in order to enrich pharmaceutical companies.

(CIDRAP News) – An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.

(CIDRAP News) – An influenza expert who formerly headed the World Health Organization's (WHO's) flu program and now works for Novartis has suggested developing a prepandemic vaccine to get the jump on the next flu pandemic—an idea that other experts are greeting with caution or skepticism.

(CIDRAP News) – With pandemic flu activity declining over the past few months, businesses have a chance to retool some of their response plans, while many grapple with issues such as protective equipment shelf life and how to protect employees when pandemic or seasonal flu returns, corporate executives said today at a webinar.